Sermorelin

Growth Hormone Optimization Subcutaneous Injectable

Sermorelin is a 29-amino-acid fragment of growth-hormone-releasing hormone (GHRH). It's a gentler first-line option for clients new to peptide therapy or wanting a milder introduction to GH optimization. Effects are physiologic and reversible — your own pituitary stays in charge.

Best for: Mild GH decline, sleep quality, gradual body composition support, peptide-naïve patients.

Lab-guided protocolsPersonalized dosingProvider-led oversightIn-clinic & telehealth Lab-guided protocolsPersonalized dosingProvider-led oversightIn-clinic & telehealth

The questions, answered.

  • Restores age-related GH decline with a gentle, physiologic profile.
  • Improves sleep quality and depth.
  • Gradual body composition support over months.
  • Excellent tolerability profile for first-time peptide users.
  • Supports recovery and exercise capacity.
  • Reversible: own pituitary remains in control throughout.
  • GHRH receptor activation: stimulates natural pituitary GH release.
  • Preserves pulsatile rhythm — no continuous exogenous GH.
  • IGF-1 elevation to youthful range without supraphysiologic spikes.
  • Negative-feedback respected: the body's own regulation stays intact.
  • Weeks 1–2: Subtle improvements in sleep depth and recovery from exercise.
  • Weeks 4–6: Body composition and energy gains become noticeable; labs show IGF-1 trending up.
  • Weeks 8–12: Substantive improvements consolidate; many clients continue at maintenance dose.
  • Injection-site reactions: mild and uncommon.
  • Headache or facial flushing: typically resolves within 30 minutes of dosing.
  • Dizziness — rare and short-lived.
  • Vivid dreams from improved sleep depth.
  • Dose at night before bed for natural GH pulse timing.
  • No food 1 hour before/after the injection.
  • Be patient: Sermorelin's effects are gradual and compound over months.
  • Reassess with labs at 12 weeks to confirm IGF-1 response.
  • Active malignancy without oncology guidance.
  • Severe respiratory disease — discuss with provider.
  • Pregnancy or breastfeeding.
  • Known peptide allergy.
Important Note The FDA's position on peptides continues to evolve. Availability of specific compounds may change, and not all peptides discussed are currently offered at every visit. Book a consultation with our provider team to discuss your goals, current options, and what's appropriate for you.

Layered with intention.

— Begin

Precision protocols.
Designed around you.

Every TAI peptide protocol is lab-guided and provider-led. Start with biomarkers, design around your goals, refine at intervals. Available in-clinic and via telehealth.

Book Consult Membership pricing